» Articles » PMID: 37629100

Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Aug 26
PMID 37629100
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy (DR) is a major complication of diabetes and a leading cause of blindness worldwide. DR was recently defined as a neurovascular disease associated with tissue-specific neurovascular impairment of the retina in patients with diabetes. Neurovascular cell death is the main cause of neurovascular impairment in DR. Thus, neurovascular cell protection is a potential therapy for preventing the progression of DR. Growing evidence indicates that a variety of cell death pathways, such as apoptosis, necroptosis, ferroptosis, and pyroptosis, are associated with neurovascular cell death in DR. These forms of regulated cell death may serve as therapeutic targets for ameliorating the pathogenesis of DR. This review focuses on these cell death mechanisms and describes potential therapies for the treatment of DR that protect against neurovascular cell death.

Citing Articles

Translational Research and Therapies for Neuroprotection and Regeneration of the Optic Nerve and Retina: A Narrative Review.

Oshitari T Int J Mol Sci. 2024; 25(19).

PMID: 39408817 PMC: 11476551. DOI: 10.3390/ijms251910485.


Resveratrol Protects Müller Cells Against Ferroptosis in the Early Stage of Diabetic Retinopathy by Regulating the Nrf2/GPx4/PTGS2 Pathway.

Wang Y, Song S, Song Y, Wang Y, Wan Z, Sun P Mol Neurobiol. 2024; 62(3):3412-3427.

PMID: 39292340 DOI: 10.1007/s12035-024-04496-8.


Peptain-1 blocks ischemia/reperfusion-induced retinal capillary degeneration in mice.

Nam M, Dhillon A, Nahomi R, Carrillo N, Hougen C, Nagaraj R Front Cell Neurosci. 2024; 18:1441924.

PMID: 39149168 PMC: 11324586. DOI: 10.3389/fncel.2024.1441924.


Microvascular destabilization and intricated network of the cytokines in diabetic retinopathy: from the perspective of cellular and molecular components.

Sheng X, Zhang C, Zhao J, Xu J, Zhang P, Ding Q Cell Biosci. 2024; 14(1):85.

PMID: 38937783 PMC: 11212265. DOI: 10.1186/s13578-024-01269-7.


Rejuvenation of diabetic macular edema with senolytic therapy.

Murakami T, Gardner T Nat Med. 2024; 30(2):346-347.

PMID: 38332040 DOI: 10.1038/s41591-024-02804-2.

References
1.
Spyridakos D, Mastrodimou N, Vemuri K, Ho T, Nikas S, Makriyannis A . Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. Int J Mol Sci. 2023; 24(1). PMC: 9820336. DOI: 10.3390/ijms24010240. View

2.
Segawa K, Kurata S, Nagata S . Human Type IV P-type ATPases That Work as Plasma Membrane Phospholipid Flippases and Their Regulation by Caspase and Calcium. J Biol Chem. 2015; 291(2):762-72. PMC: 4705396. DOI: 10.1074/jbc.M115.690727. View

3.
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K . ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 2002; 16(11):1345-55. PMC: 186318. DOI: 10.1101/gad.992302. View

4.
Shao J, Bai Z, Zhang L, Zhang F . Ferrostatin-1 alleviates tissue and cell damage in diabetic retinopathy by improving the antioxidant capacity of the Xc-GPX4 system. Cell Death Discov. 2022; 8(1):426. PMC: 9596714. DOI: 10.1038/s41420-022-01141-y. View

5.
Miotto G, Rossetto M, Di Paolo M, Orian L, Venerando R, Roveri A . Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 2019; 28:101328. PMC: 6812032. DOI: 10.1016/j.redox.2019.101328. View